17 February 2022

Amarex Taiwan Chief Operating Officer, Dr. Chia-Hua Maggie Ho, Featured in 2021 End-of-year Global Bio Investment Article: Bringing U.S. FDA Review Criteria to the Taiwanese Biotech Industry

Taipei, Taiwan (February 17) - Many non-COVID-19 global clinical trials are delayed or terminated early due to the COVID-19 pandemic. The clinical trials carried out by Amarex were not forced to be suspended or terminated during the pandemic. Amarex set up the monitoring plan and audit system remotely and that not only overcomes the difficulty of on-site monitoring but also ensures the quality of clinical trials and the safety and rights of subjects.

02 November 2021

Amarex Taiwan Exhibiting at BIO Asia-Taiwan 2021 | Nov. 4-7 | Taipei, Taiwan

​Taipei, Taiwan (November 02, 2021) – We are pleased to announce that Amarex Taiwan, LLC is exhibiting at BIO Asia-Taiwan 2021, held November 4-7 at the Taipei Nangang Exhibition Center in Taiwan.

16 September2021

Amarex Passes Taiwan FDA GTP Audit: Result is a Resounding No Findings

​Taipei, Taiwan (September 16, 2021) – Amarex Taiwan, LLC announces a no findings result of a Taiwan Food and Drug Administration (TFDA) audit of its office last month.

24 February 2021

Amarex Featured in 15-year Anniversary Issue of the NSF International Journal

The just released Issue 48 of NSF International’s Health Science Journal features contributions by Amarex. The journal is available at https://www.nsf.org/periodicals/health-sciences-journal/issue-48.

15 February 2021

Amarex Job Openings at the BioCapital Life Sciences Career Fair | Feb. 18, 2021

We are featuring current job openings at the MD Tech Council BioCapital Life Sciences Career Fair, Thursday, February 18th. This virtual event is free and open to all students and job seekers interested in career opportunities in the life sciences industry. Register for this virtual event, visit our booth, and speak to an Amarex representative about expanding your career: mdls.vfairs.com.

25 January 2021

Enrichment Strategies to Increase the Power/Reduce the Sample Size in Clinical Trials

On January 07, Dr. Kazem Kazempour, President & CEO, conducted the webinar Enrichment Strategies to Increase the Power/Reduce the Sample Size in Clinical Trials. View the full webinar recording on our YouTube channel.

18 January 2021

 Severe-to-Critical COVID-19 Patient Clinical Trial Reaches Full Enrollment  

Our client’s Phase III clinical trial for patients with severe-to-critical COVID-19 symptoms reached full enrollment (390 patients) in mid-December. Data analysis results are expected this quarter. The trial was conducted in the U.S., Canada, and U.K..